Center of Excellence in Complex Disease Genetics-from Discovery to Precision Medicine

Acronym

CoECDG

Description of the granted funding

Human genetics has proven to be instrumental for identifying novel molecular mechanisms underlying common complex diseases and holds the promise of improved, targeted treatment as well as prediction, prevention and diagnosis. Building on unique resources and extensive track record in disease genetic studies in Finland, the Centre of Excellence in Complex Disease Genetics (CoECDG) develops and applies strategies for the identification of risk and protective variants, with focus on high-impact low-frequency alleles that contribute significantly to common diseases, and to implement strategies for genomic precision medicine. The CoECDG will also lead national efforts to implement genomic findings into prevention and personalized treatment of common complex diseases. In our second funding term, we expand our activities to new disease areas and develop strategies for better understanding the mechanisms through which genes contribute to disease, disease progression and treatment responses.
Show more

Starting year

2023

End year

2025

Granted funding







Samuli Ripatti Orcid -palvelun logo
1 359 421 €

Role in consortium of the Academy of Finland

Leader

Other consortium parties

Partner
University of Helsinki (352793)
630 999 €
Partner
University of Helsinki (352794)
508 912 €
Partner
University of Helsinki (352795)
530 488 €
Partner
University of Helsinki (352796)
407 847 €
Partner
University of Helsinki (352791)
858 157 €
Partner
University of Helsinki (352792)
500 176 €

Funder

Research Council of Finland

Funding instrument

Centre of Excellence programmes

Decision maker

Suomen akatemian muu päättäjä
13.12.2022

Other information

Funding decision number

352790

Fields of science

Biomedicine

Research fields

Biolääketieteet

Identified topics

genes, genetics